Antimitochondrial antibody negative primary biliary cirrhosis in Japan: Utilization of clinical data when patients applied to receive public financial aid

Journal of Epidemiology

Volumn 16, Issue 1, 2005, Pages 30-34

  Sakauchi, Fumio ^a   Mori, Mitsuru ^a   Zeniya, Mikio ^b   Toda, Gotaro ^c  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Senpo Tokyo Takanawa Hospital   (Japan)

Author keywords

Antimitochondrial antibody; Complications; Cross sectional studies; Liver cirrhosis, biliary

Indexed keywords

ANTIBODY;

AGED; ARTICLE; BILIARY CIRRHOSIS; BLOOD; CHOLANGITIS; CROSS-SECTIONAL STUDY; ECONOMICS; FEMALE; HUMAN; IMMUNOLOGY; JAPAN; MALE; MIDDLE AGED;

AGED; ANTIBODIES; CHOLANGITIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; JAPAN; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED;

EID: 30344476115     PISSN: 09175040     EISSN: None     Source Type: Journal    
DOI: 10.2188/jea.16.30     Document Type: Article

References (26)

1. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996; 335: 1570-80.
2. Lindor KD, Dickson ER. Primary biliary cirrhosis. In: Schiff ER, Sorrel MF, and Maddrey WC, eds. Schiff s diseases of the liver, 8th ed. Philadelphia: Lippincott-Raven Publishers; 1999: 679-92.
3. Sakauchi F, Mori M, Zeniya M, Toda G. A cross-sectional study of primary biliary cirrhosis in Japan: Utilization of clinical data when patients applied to receive public financial aid. J Epidemiol 2005; 15: 24-8.
4. Sasaki H, Inoue K, Higuchi K, Yasuyama T, Koyata H, Kuroki T, et al. Primary biliary cirrhosis in Japan: National survey by the subcommittee on autoimmune hepatitis. Gastroenterol Jpn 1985; 20: 476-85.
5. Inoue K, Hirohara J, Nakano T, Seki T, Sasaki H, Higuch K, et al. Prediction of prognosis of primary biliary cirrhosis in Japan. Liver 1995; 15: 70-7.
6. Nakano T, Inoue K, Hirohara J, Arita S, Higuchi K, Omata M, et al. Long-term prognosis of primary biliary cirrhosis (PBC) in Japan and analysis of factors of stage progression in asymptomatic PBC (a-PBC). Hepatol Res 2002; 22: 250-60.
7. Mori M, Tamakoshi A, Kojima M, Kawamura T, Ohno Y, Shiratori Y, et al. Nationwide epidemiological survey on intractable hepatic disorders in Japan. In: Annual report of research committee on epidemiology of intractable diseases; 1997: 27.
8. Kim WR, Ludwig J, Lindor KD. Variant forms of cholestatic diseases involving small bile ducts in adults. Am J Gastroenterol 2000; 95: 1130-8.
9. Olsen NJ, Kovacs WJ. Gonadal steroids and immunity. Endocr Rev 1996; 17: 369-84.
10. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001; 2: 777-80.
11. Michieletti P, Wanless IR, Katz A, Scheuer PJ, Yeaman SJ, Bassendine MF, et al. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut 1994; 35: 260-5.
12. Lacerda MA, Ludwig J, Dickson ER, Jorgensen RA, Lindor KD. Antimitochondrial antibody-negative primary biliary cirrhosis. Am J Gastroenterol 1995; 90: 247-9.
13. Sánchez-Pobre P, Castellano G, Colina F, Dominguez P, Rodriguez S, Canga F, et al. Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. J Clin Gastroenterol 1996; 23: 191-8.
14. Ben-Ari Z, Dhillon AP, Sherlock S. Autoimmune cholangiopathy: parts of the spectrum of autoimmune chronic active hepatitis. Hepatology 1993; 18: 10-5.
15. Gordon SC, Quattrociocchi-Longe TM, Khan BA, Kodali VP, Chen J, Silverman Al, et al. Antibodies carbonic anhydrase in patients with immune cholangiopathies. Gastroenterology 1995; 108: 1802-9.
16. Kitami N, Komada T, Ishii H, Shimizu H, Adachi H, Yamaguchi Y, et al. Immunological study of anti-M2 in antimitochondrial antibody-negative primary biliary cirrhosis. Intern Med 1995; 34: 496-501.
17. Heathcote J. Update on primary biliary cirrhosis. Can J Gastroenterol 2000; 14: 43-8.
18. Taylor SL, Dean PJ, Riely CA. Primary autoimmune cholangitis: an alternative to antimitochondrial antibody-negative primary biliary cirrhosis. Am J Surg Pathol 1994; 18: 91-9.
19. Goodman ZD, McNally PR, Davis DR, Ishak KG. Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlation in 200 cases. Dig Dis Sci 1995; 40: 1232-42.
20. Manns MP. Recent developments in autoimmune liver diseases. J Gastroenterol Hepatol 1997; 12: S256-S71.
21. Gisbert JP, Jones EA, Pajares JM, Moreno-Otero R. Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)?. Aliment Pharmacol Ther 2003; 17: 17-27.
22. Akisawa N, Nishimori I, Miyaji E, Iwasaki S, Maeda T, Shimizu H, et al. The ability of anti-carbonic anhydrase II antibody to distinguish autoimmune cholangitis from primary biliary cirrhosis in Japanese patients. J Gastroenterol 1999; 34: 366-71.
23. Tsuneyama K, Van de Water J, Van Thiel D, Coppel R, Ruebner B, Nakanuma Y, et al. Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochndrial antibody-nagative primary biliary cirrhosis. Hepatology 1995; 22: 1440-6.
24. Invernizzi P, Crosignani A, Battezzati PM, Covini G, De Valle G, Larghi A, et al. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology 1997; 25: 1090-5.
25. Nakanuma Y, Harada K, Kaji K, Terasaki S, Tsuneyama K, Moteki S, et al. Clinicopathological study of primary biliary cirrhosis negative for antimitochondrial antibodies. Liver 1997; 17: 281-7.
26. Miyakawa H, Tanaka A, Kikuchi K, Matsushita M, Kitazawa E, Kawaguchi N, et al. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology 2001; 34: 243-8.